Evidence map›Paper›PMID 28533364›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Changes in conformational equilibria regulate the activity of the Dcp2 decapping enzyme.

Jan Philip Wurm, Iris Holdermann, Jan H Overbeck, Philipp H O Mayer, Remco Sprangers

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Assessing the applicability ofJournal of biomolecular NMR · 2023
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Dcp2 C-terminaleLife · 2022
    Article
  15. Article
  16. Eukaryotic mRNA Decapping Activation.Frontiers in genetics · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jan Philip WurmMax Planck Institute for Developmental Biology, 72076 Tuebingen, Germany.
Iris HoldermannMax Planck Institute for Developmental Biology, 72076 Tuebingen, Germany.
Jan H OverbeckMax Planck Institute for Developmental Biology, 72076 Tuebingen, Germany.
Philipp H O MayerMax Planck Institute for Developmental Biology, 72076 Tuebingen, Germany.
Remco SprangersMax Planck Institute for Developmental Biology, 72076 Tuebingen, Germany Remco.Sprangers@biologie.uni-regensburg.de.
Max Planck Institute for Developmental Biology · DE

Funding

European Research Council 616052
6 · The paper itself

Abstract

Crystal structures of enzymes are indispensable to understanding their mechanisms on a molecular level. It, however, remains challenging to determine which structures are adopted in solution, especially for dynamic complexes. Here, we study the bilobed decapping enzyme Dcp2 that removes the 5' cap structure from eukaryotic mRNA and thereby efficiently terminates gene expression. The numerous Dcp2 structures can be grouped into six states where the domain orientation between the catalytic and regulatory domains significantly differs. Despite this wealth of structural information it is not possible to correlate these states with the catalytic cycle or the activity of the enzyme. Using methyl transverse relaxation-optimized NMR spectroscopy, we demonstrate that only three of the six domain orientations are present in solution, where Dcp2 adopts an open, a closed, or a catalytically active state. We show how mRNA substrate and the activator proteins Dcp1 and Edc1 influence the dynamic equilibria between these states and how this modulates catalytic activity. Importantly, the active state of the complex is only stably formed in the presence of both activators and the mRNA substrate or the m7GDP decapping product, which we rationalize based on a crystal structure of the Dcp1:Dcp2:Edc1:m7GDP complex. Interestingly, we find that the activating mechanisms in Dcp2 also result in a shift of the substrate specificity from bacterial to eukaryotic mRNA.

Indexed as

Catalytic DomainCrystallography, X-RayEndoribonucleasesMagnetic Resonance SpectroscopyModels, MolecularProtein ConformationRNA-Binding ProteinsRNA Cap-Binding ProteinsRNA CapsRNA, MessengerRNA StabilitySchizosaccharomycesSchizosaccharomyces pombe ProteinsDcp1 protein, S pombeDcp2 protein, S pombeEdc1 protein, S pombeEndoribonucleasesmRNA decapping enzymesRNA-Binding ProteinsRNA Cap-Binding ProteinsRNA CapsRNA, MessengerSchizosaccharomyces pombe Proteinscatalytic activityDcp2mRNA decappingNMR spectroscopyprotein dynamics

Identifiers

PMID28533364
PMCPMC5468633
OpenAlexW2620221124

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.